The critical need to control systemic disease in breast cancer patients who have received stereotactic radiosurgery to brain metastases – Wilmot Cancer Institute
Wilmot Cancer Institute shared on LinkedIn a recent paper by Alex Schick et al. titled “Impact of systemic disease on CNS disease control after stereotactic radiosurgery to breast cancer brain metastases (The SYBRA Study)” published in npj Breast Cancer.
Authors: Alex Schick et al.
“New University of Rochester Research led by Ajay Dhakal, MBBS, highlights the critical need to control systemic disease among patients with breast cancer who have received stereotactic radiosurgery to brain metastases.
In the study, published in npj Breast Cancer (a Nature Portfolio journal), patients with early systemic disease progression had significantly worse central nervous system (CNS) failure-free survival and overall survival compared to those without early systemic disease progression.”
Source: Wilmot Cancer Institute/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023